Name | Symbol | Markt | Aktientyp |
---|---|---|---|
Kyverna Therapeutics Inc | KYTX | NASDAQ | Common Stock |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
13,48 | 12,77 | 13,625 | 13,07 | 13,52 |
Aktuelle News
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
11.6.2024 | 00:56 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
10.6.2024 | 22:05 | PRNUS | Kyverna Therapeutics and National Institutes of Health.. |
07.6.2024 | 22:06 | PRNUS | Kyverna Therapeutics to Present Data on 50 Patient.. |
29.5.2024 | 22:33 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
14.5.2024 | 22:29 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
14.5.2024 | 22:25 | EDGAR2 | Form 8-K - Current report |
14.5.2024 | 22:05 | PRNUS | Kyverna Therapeutics Provides Business Update and Reports.. |
11.4.2024 | 23:01 | PRNUS | Kyverna Therapeutics to attend the 2024 American Academy of.. |
29.3.2024 | 19:59 | PRNUS | First-in-Disease Use of Kyverna Therapeutics' KYV-101 in.. |
26.3.2024 | 21:05 | PRNUS | Kyverna Therapeutics Provides Business Update and Reports.. |
08.3.2024 | 01:26 | PRNUS | Kyverna Therapeutics and Stanford University Agree to.. |
12.2.2024 | 22:39 | PRNUS | Kyverna Therapeutics Announces Closing of Initial Public.. |